- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
Endogenous Opioid Peptide · Educational Resource
Understanding MET-Enkephalin and Immune Modulation Research
Peptide Classification
Endogenous opioid pentapeptide (delta-opioid receptor ligand)
Target Application in Literature
Investigational immune modulation and pain-pathway research
Administration Protocol in Studies
Subcutaneous (subq) pen delivery
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →Endogenous Opioid Peptide · Educational Resource
Understanding MET-Enkephalin and Immune Modulation Research
01 — Overview
What is MET-Enkephalin?
MET-Enkephalin (methionine-enkephalin) is a naturally occurring opioid pentapeptide—one of the first endogenous opioids identified in the body—that researchers study for its dual roles in pain-pathway modulation and immune cell regulation, sometimes referenced in literature under the name opioid growth factor (OGF).
To understand its biological role, it helps to think of MET-Enkephalin as one of the body's own natural pain-relief chemicals, similar in concept to endorphins, but with an additional, less commonly known role: acting as a signal that can influence how quickly certain cells divide and how actively immune cells respond.
Scientific literature categorizes MET-Enkephalin as an investigational compound. By administering a synthetic version of this naturally occurring peptide, researchers can study its receptor-binding behavior and downstream immune and cell-regulatory effects under controlled laboratory conditions.
02 — How it works
How It Works: Delta-Opioid Receptor and Immune Signaling
The primary mechanism researchers evaluate when studying MET-Enkephalin is its capacity to bind to delta-opioid receptors distributed throughout the nervous and immune systems, contributing to endogenous pain modulation.
Separately, under its opioid growth factor designation, studies also evaluate MET-Enkephalin's interaction with the opioid growth factor receptor (OGFr), a distinct, non-classical opioid receptor studied for its role in regulating cell proliferation and modulating natural killer (NK) cell and T-cell activity.
Administration in Research
In modern observational studies and laboratory applications, delivery methodologies focus exclusively on the use of a subq pen (subcutaneous delivery). This delivery system is prioritized in current protocols because it allows for precise, localized, and highly controlled micro-dosing directly into the subcutaneous layer to observe systemic opioid receptor and immune-signaling effects.
03 — Areas of research
Summary of Investigated Research Areas
Ongoing preclinical and clinical studies evaluate MET-Enkephalin across several key physiological systems, particularly relating to pain-pathway modulation, immune cell activity, and cell proliferation regulation.
Endogenous Pain Pathway Modulation
Clinical literature evaluates MET-Enkephalin's binding to delta-opioid receptors involved in the body's natural pain-regulation pathways.
NK Cell Activity Research
Studies examine MET-Enkephalin's association with enhanced natural killer cell activity as an immune-modulating agent.
T-Cell Function Studies
Research investigates MET-Enkephalin's effects on T-lymphocyte proliferation and immune response regulation.
Opioid Growth Factor Receptor (OGFr) Signaling
Investigations evaluate MET-Enkephalin's interaction with the non-classical OGF receptor implicated in cell-cycle regulation.
Adjunctive Oncology Research
Early-phase clinical research has explored MET-Enkephalin, studied under the name opioid growth factor, as an adjunct alongside standard treatment protocols in select cancer research contexts.
Wound & Corneal Healing Research
Preclinical models evaluate opioid growth factor-related pathways in epithelial healing and corneal re-epithelialization.
04 — FAQ
Frequently Asked Questions
Ano ba ang MET-Enkephalin at para saan ito?
Ang MET-Enkephalin ay isang natural na opioid peptide na ginagawa ng katawan, pinag-aaralan para sa potential role nito sa pain modulation at pagsuporta sa immune system, tulad ng NK cell at T-cell activity.
Approved ba ng FDA ang MET-Enkephalin?
Like many advanced peptide protocols, MET-Enkephalin is not a mass-manufactured, off-the-shelf medication, meaning it does not go through the standard FDA approval process designed for commercial retail drugs. Instead, medical-grade peptides are utilized as specialized, investigational therapies.
Kumbaga, they are custom-prepared rather than mass-produced. Sa Pilipinas at globally, accessing these types of biological protocols safely requires a thorough medical consultation and a doctor’s prescription. When properly prescribed, they are formulated by strictly regulated, licensed compounding pharmacies.
Paano ginagamit ang MET-Enkephalin sa mga scientific studies?
Current research and application protocols focus strictly on the use of a subq pen for delivery. This method is utilized by researchers to ensure highly accurate, controlled administration when evaluating the peptide’s effects on opioid receptor pathways and immune cell activity.
What makes it different from other biological compounds?
Unlike peptides studied for a single biological system, MET-Enkephalin is unique because literature highlights its dual identity—functioning as both an endogenous opioid involved in pain regulation and, under the name opioid growth factor, a signal studied for its role in cell proliferation and immune cell activity.
05 — References
References and Academic Literature
Hughes, J., Smith, T. W., Kosterlitz, H. W., et al. (1975). Identification of two related pentapeptides from the brain with potent opiate agonist activity.. Nature, 258(5536), 577-580.
Zagon, I. S., & McLaughlin, P. J. (2005). Opioid growth factor and the treatment of human pancreatic cancer: a phase I clinical trial.. Anticancer Research, 25(5), 3651-3657.
Plotnikoff, N. P., Faith, R. E., Murgo, A. J., et al. (1997). Methionine enkephalin: a new cytokine—human studies.. Clinical Immunology and Immunopathology, 82(2), 93-101.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups